Author

K. Parag-Sharma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein design· 1 Assay:protein structure· 1

Frequent Co-Authors

A. Chatterjee· 1 shared A. L. Amelio· 1 shared A. Luebbers· 1 shared A. M. Musicant· 1 shared A. Marivin· 1 shared C. A. Flaveny· 1 shared D. N. Hayes· 1 shared E. C. Henry· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Chatterjee

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Optogenetic activation of heterotrimeric Gi proteins by LOV2GIVe - a rationally engineered modular protein

M. Garcia-Marcos, K. Parag-Sharma, A. Marivin, M. Maziarz, A. Luebbers, L. T. Nguyen

The paper introduces LOV2GIVe, a modular protein that optogenetically activates Gi proteins using blue light, offering a new tool for precise G-protein manipulation.

bioRxiv · Aug 17, 2020Biochemistry

CRTC1-MAML2 Establishes a PGC1α-IGF1 Circuit that Confers Vulnerability to PPARγ Inhibition

A. M. Musicant, K. Parag-Sharma, W. Gong, M. Sengupta, A. Chatterjee, E. C. Henry, Y.-H. Tsai, M. Hayward, S. Sheth, R. Betancourt, T. Hackman, R. J. Padilla, J. S. Parker, J. Giudice, C. A. Flaveny, , A. L. Amelio

This study identifies a CRTC1-MAML2-driven transcriptional circuit involving PGC-14 and IGF-1 that makes mucoepidermoid carcinoma cells vulnerable to PPARγ inhibition.

bioRxiv · Jun 3, 2020 · PreprintCancer Biology